To include your compound in the COVID-19 Resource Center, submit it here.

Resolute: Additional Phase IV data

Additional data from the open-label, international Phase IV RESOLUTE All Comers trials in 2,292 patients undergoing percutaneous coronary

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE